Skip to main content

Table 5 CTGF/log10 (VEGF) ratios

From: The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage

Variables

Value

P value

Group B

Ratio CTGF/log10(VEGF) before IVR

0.399 ± 0.141

0.051

Ratio CTGF/log10(VEGF) after IVR

0.724 ± 0.624

 

Group C

Ratio CTGF/log10(VEGF) before IVR

0.553 ± 0.284

0.046

Ratio CTGF/log10(VEGF) after IVR

0.803 ± 0.387

 
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us